1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Therapeutic Drug Monitoring Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Data Management Services
6.4. Equipment

7. Therapeutic Drug Monitoring Market, by Technology
7.1. Introduction
7.2. Immunoassays
7.3. Proteomic Technologies

8. Therapeutic Drug Monitoring Market, by Drug Class
8.1. Introduction
8.2. Anti-arrhythmics
8.3. Anti-epileptics
8.4. Antibiotics
8.5. Immunosuppressants

9. Therapeutic Drug Monitoring Market, by End-User
9.1. Introduction
9.2. Hospital Labs
9.3. Private Labs

10. California Therapeutic Drug Monitoring Market

11. Florida Therapeutic Drug Monitoring Market

12. Illinois Therapeutic Drug Monitoring Market

13. New York Therapeutic Drug Monitoring Market

14. Ohio Therapeutic Drug Monitoring Market

15. Pennsylvania Therapeutic Drug Monitoring Market

16. Texas Therapeutic Drug Monitoring Market

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Abbott Laboratories, Inc.
18.2. Agilent Technologies, Inc.
18.3. Alere, Inc.
18.4. apDia Group
18.5. ARK Diagnostics, Inc.
18.6. Beckman Coulter, Inc.
18.7. Bio-Rad Laboratories, Inc.
18.8. bioMérieux SA
18.9. Buehlmann Laboratories AG
18.10. Cambridge Life Sciences Limited
18.11. Chromsystems Instruments & Chemicals GmbH
18.12. Danaher Corporation
18.13. DiaSystem Scandinavia AB
18.14. Exagen
18.15. F. Hoffmann-La Roche AG
18.16. Grifols, S.A.
18.17. InSource Diagnostics
18.18. Merck KGaA
18.19. Miraca Holdings, Inc
18.20. Myriad Genetics, Inc.
18.21. R-Biopharm AG
18.22. Randox Laboratories Limited
18.23. Sekisui Medical Co., Ltd
18.24. Siemens Healthineers AG
18.25. SQI Diagnostics
18.26. Tecan Trading AG
18.27. Theradiag
18.28. Thermo Fisher Scientific, Inc.

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT , 2020 VS 2027 (%)
FIGURE 4. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT , 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT , 2027
FIGURE 6. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CONSUMABLES, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CONSUMABLES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (%)
FIGURE 13. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 15. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PROTEOMIC TECHNOLOGIES, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PROTEOMIC TECHNOLOGIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS , 2020 VS 2027 (%)
FIGURE 20. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS , 2020 VS 2027 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS , 2027
FIGURE 22. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTI-ARRHYTHMICS, 2018-2027 (USD MILLION)
FIGURE 23. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTI-ARRHYTHMICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTI-EPILEPTICS, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTI-EPILEPTICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIBIOTICS, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIBIOTICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 30. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
FIGURE 31. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2020 VS 2027 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2027
FIGURE 33. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY HOSPITAL LABS, 2018-2027 (USD MILLION)
FIGURE 34. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY HOSPITAL LABS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 35. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRIVATE LABS, 2018-2027 (USD MILLION)
FIGURE 36. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRIVATE LABS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 37. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: FPNV POSITIONING MATRIX
FIGURE 38. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 39. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES THERAPEUTIC DRUG MONITORING MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CONSUMABLES, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PROTEOMIC TECHNOLOGIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS , 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTI-ARRHYTHMICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTI-EPILEPTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIBIOTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY HOSPITAL LABS, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRIVATE LABS, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: SCORES
TABLE 19. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: BUSINESS STRATEGY
TABLE 20. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: PRODUCT SATISFACTION
TABLE 21. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: RANKING
TABLE 22. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 23. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: MERGER & ACQUISITION
TABLE 24. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 25. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 26. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: INVESTMENT & FUNDING
TABLE 27. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 28. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Alere, Inc.
apDia Group
ARK Diagnostics, Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
bioMérieux SA
Buehlmann Laboratories AG
Cambridge Life Sciences Limited
Chromsystems Instruments & Chemicals GmbH
Danaher Corporation
DiaSystem Scandinavia AB
Exagen
F. Hoffmann-La Roche AG
Grifols, S.A.
InSource Diagnostics
Merck KGaA
Miraca Holdings, Inc
Myriad Genetics, Inc.
R-Biopharm AG
Randox Laboratories Limited
Sekisui Medical Co., Ltd
Siemens Healthineers AG
SQI Diagnostics
Tecan Trading AG
Theradiag
Thermo Fisher Scientific, Inc.